Japan’s DeNA built its empire from games for feature phones and desktop PCs, but its legacy in leisure isn’t stopping it from tackling more serious matters. The company announced today it has formed the aptly named DeNA Life Science Inc, a wholly-owned company subsidiary specializing in health care.
The branch’s first project is a genetic testing service called Mycode, which will be developed in partnership with the Institute of Medical Science at the University of Tokyo.
Researchers from both institutions will work together to develop “Japanese-specific disease risk prediction algorithms required for providing a highly reliable and accurate genetic testing service.”
It’s not clear what that entails specifically, but if direct-to-consumer genetic testing services like 23andMe are any indication, the venture will likely involve genome mapping with an eye towards disease prevention.
Read the full, original story: Japanese gaming giant DeNA ventures into DNA with new genetic testing service
